Glen Santangelo

Stock Analyst at Jefferies

(0)
# 4103
Out of 5,240 analysts
104
Total ratings
34.88%
Success rate
-6.20%
Average return
47 Stocks
Name Action Price Target Current % Upside Ratings Updated
Pacira BioSciences
Maintains: Strong Buy
15 18
20.55 -12.41% 5 Sep 24, 2024
Progyny
Maintains: Buy
31 24
20.08 19.52% 4 Sep 19, 2024
Teladoc Health
Maintains: Hold
8 10
9.35 6.95% 6 Sep 17, 2024
Viatris
Reinstates: Buy
15
11.71 28.1% 3 Jul 19, 2024
Hims & Hers Health
Maintains: Hold
14 23
26.19 -12.18% 4 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
19 23
21 9.52% 4 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
41 44
33.15 32.73% 3 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
17
11.69 45.42% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
230
164.36 39.94% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.66 1415.15% 2 Dec 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
70
38.47 81.96% 2 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
14
6.85 104.38% 2 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Hold
3
n/a n/a 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
6
1.23 347.15% 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
4
3.21 24.61% 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
6.78 135.99% 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
14
3.42 309.36% 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
75
5.02 1394.02% 1 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
78 46
50.67 -9.22% 2 May 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
62 80
103.56 -22.75% 2 Mar 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
31 28
5.88 376.19% 2 Mar 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
225
n/a n/a 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
70
26.1 168.2% 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
120
8.04 1392.54% 3 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
13
n/a n/a 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
2
2.83 -29.33% 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
47
4.13 1038.01% 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
n/a n/a 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
3.92 818.37% 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
125 130
n/a n/a 2 Mar 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Mar 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
173 169
594.02 -71.55% 5 May 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
28.55 -22.94% 1 May 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
n/a n/a 1 Apr 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 Jan 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Dec 16, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
4
n/a n/a 4 Sep 12, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
85 90
n/a n/a 5 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
160 170
n/a n/a 3 May 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
79 82
71.25 15.09% 2 Apr 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
81
18.02 349.5% 1 Dec 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
34
n/a n/a 1 Dec 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
250
210.51 18.76% 1 Dec 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
45
n/a n/a 1 Dec 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
78
12.26 536.22% 1 Dec 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
n/a n/a 6 Dec 4, 2017